General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Portola(SIGNIFICANT), Pfizer Inc(SIGNIFICANT), Veralox(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), Humacyte(MODEST), Antev(MODEST), Akros(MODEST), Artivion(MODEST), Bristol Myers Squibb(MODEST), Ferring Pharmaceuticals(MODEST), Janssen Pharmaceuticals, Inc(MODEST), Novostia(MODEST) RESEARCH/RESEARCH GRANTS: CSL Behring (SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Artivion(SIGNIFICANT), Ferring Pharmaceuticals(SIGNIFICANT), Bristol Myers Squibb(SIGNIFICANT)

View Full Disclosure